Cargando…
Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review
BACKGROUND: Adjuvant endocrine therapies are known to induce undesirable adverse effects such as vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients. Drugs used in these therapies are often metabolised by cytochrome P450 (CYP) enzymes, in which their metabolising activities...
Autores principales: | Chan, Carmen W. H., Law, Bernard M. H., Ng, Marques S. N., Wong, Corinna C. Y., Wong, Carissa W. Y., Quinley, Morgan, Orgusyan, Jessica M., Chow, Ka Ming, Waye, Mary M. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130378/ https://www.ncbi.nlm.nih.gov/pubmed/34006247 http://dx.doi.org/10.1186/s12885-021-08268-8 |
Ejemplares similares
-
Reductive Cytochrome P450 Reactions and Their Potential Role in Bioremediation
por: Behrendorff, James B. Y. H.
Publicado: (2021) -
The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021) -
Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers
por: Yu, M-W, et al.
Publicado: (1999) -
Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update
por: Chan, Carmen W. H., et al.
Publicado: (2017) -
Basic Review of the Cytochrome P450 System
por: McDonnell, Anne M, et al.
Publicado: (2013)